Fantastic Bioimaging Co., Ltd.（FAB） was established in 2012 which provides independent medical imaging service of clinical trials for the pharmaceutical, biotech and medical device industries. The founder and CEO of FAB, Dr. Liang Luxia, is a senior expert in the field of medical imaging. As the pioneer and leading figure of local medical imaging CRO in China, Dr. Liang leads FAB to the forefront of the industry.
For clinical trials (Phase I~IV) with medical imaging evaluation as parts of efficacy endpoints, FAB offers specialized services of medical imaging efficacy assessment, including but not limited to Imaging acquisition protocol design, medical imaging requirement consultation, site imaging acquisition capability evaluation and Imaging data management planning. Therapeutic areas of FAB include oncology, cardiovascular disease, CNS, hematology, musculoskeletal diseases, digestive disease, dermatology, ophthalmology, medical device, contrast agent, etc.
Since its establishment, FAB has accumulated rich project experience. At present, 49 projects have been successfully submitted to the FDA/NMPA for application, and 28 projects have been approved for marketing, covering multiple disease areas. In the clinical trial endpoint evaluation process, FAB strictly controls the quality of projects and has been awarded the titles of "Most Trustworthy Imaging CRO" and "Most Professional Imaging CRO" by the sponsors.
Home
Services
Telephone
Message